Syringe News and Research

RSS

Risky injection behaviors are established at the onset of injection drug use

The circumstances surrounding the first injection experience of young injection drug users are significantly linked to future injection behavior, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions.

7 Mar 2005

28 percent of injecting drug users acquired their needles from safe sources

Nearly half of injection drug users disposed of their used syringes safely, yet only 28 percent acquired their needles from safe sources, according to a study of injection drug users in Baltimore, Md., conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

27 Feb 2005

Lack of collagen increases likelihood of osteoarthritis

Duke University Medical Center researchers have found that joints whose cartilage lacks a specific type of collagen will develop osteoarthritis – the so-called "wear-and-tear" form of the disease – at a greatly accelerated rate.

20 Feb 2005

Serono announces the availability of Saizen for adult growth hormone deficiency

Serono announced today the availability of Saizen [somatropin (rDNA origin) for injection] for use in the treatment of patients with adult growth hormone deficiency (AGHD), following its FDA approval.

10 Jan 2005

New technologies boost immunisation rates, safety

As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.

6 Dec 2004

Medication errors in sick children might be substantially higher than previously estimated

Medication errors are common in paediatric emergency departments, but the incidence of errors during paediatric resuscitation has not been fully investigated.

3 Dec 2004

Analysis of safety syringe market

One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.

2 Nov 2004

Asia must tackle HIV in injecting drug users

Asian countries must adopt strategies to slow the spread of HIV among injecting drug users, urge researchers in this week's BMJ.

23 Sep 2004

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.

14 Sep 2004

Horrifying research into Britain's injecting drug users

Horrifying research out today in the Journal of Epidemiology and Community Health, suggest that one in 50 and one in 80 adults between the ages of 15 and 44 in London, Liverpool, and Brighton is an injecting drug user. And users are more likely to die of their habit in Brighton, finds the study.

12 Aug 2004

New twist to the 2001 anthrax attacks in the U.S.

In a new twist to the 2001 anthrax attacks in the U.S., the Federal Bureau of Investigation is searching 2 homes in new York and New Jersey which may be related to the attacks.

5 Aug 2004

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

A team of researchers led by The Burnham Institute’s Robert C. Liddington has determined the crystal structure of the binding complex between anthrax toxin and one of its host receptors.

8 Jul 2004

Call for special help for young people who inject drugs

Government and health care services are being urged to make special help available for young people who inject drugs, in a bid to minimize drug-related deaths.

16 Jun 2004

New designer steroid discovered in anonymously provided syringe

A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.

14 May 2004

China recognizes 10 million Chinese may be HIV-positive by 2010

The Official Chinese News Agency reported today that the Chinese cabinet has admitted that AIDS epidemic is out of control and spreading rapidly through the country. They have also recognized the need for urgent measures to be put into place to change the situation.

9 May 2004

Russia’s harsh drug policies are fueling an AIDS epidemic

Russia’s burgeoning AIDS epidemic is fueled by government policies that deny HIV-prevention services to those most at risk and also allow discrimination against people with AIDS to flourish, Human Rights Watch said in a report released today.

29 Apr 2004

PAHO's revolving fund for immunization

A quarter century ago, the Pan American Health Organization (PAHO) and its member countries launched a unique procurement and financing mechanism to buy vaccines, syringes, and "cold chain" equipment – the basic components of their immunization programs.

21 Apr 2004

FDA approval of stomach acid suppressant

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the U.S. Food and Drug Administration (FDA) approved the reformulation of the stomach acid suppressant, PROTONIX(R) I.V. (pantoprazole sodium) for Injection.

12 Apr 2004

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

The largest study of its kind, designed to track the development of Creutzfeldt-Jakob disease in people who received human growth hormone from cadavers, has found that the vast majority of those who received the hormone did not contract the fatal condition. However, some recipients (26 out of approximately 7,700) did develop the disease.

7 Apr 2004

Launch of thin needle syringe for multiple sclerosis treatment

A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.

31 Mar 2004